The ischemia-modified albumin in relation to pacemaker and defibrillator implantation

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 1, 2008, Pages 83-87

  Sbarouni, Eftihia ^a   Georgiadou, Panagiota ^a   Panagiotakos, Demosthenes ^a   Livanis, Efthimios ^a   Theodorakis, George N ^a   Kremastinos, Dimitrios Th ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Defibrillator; Enzymes; Ischemia modified albumin; Pacemaker

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; HEART ENZYME; ISCHEMIA MODIFIED ALBUMIN; TROPONIN I;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CREATINE KINASE BLOOD LEVEL; DATA ANALYSIS; DEFIBRILLATOR; DEVICE; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PROTEIN DETERMINATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PACEMAKER, ARTIFICIAL; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC;

EID: 37549063993     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00929.x     Document Type: Article

References (23)

1. Boos CJ, Gough S, Wheather M, Medbak S, More R. Effects of transvenous pacing on cardiac troponin release. Pacing Clin Electrophysiol 2004 27 : 1264 1268.
2. Nikolaou N, Spanodimos S, Tsaglis E, Antonatos D, Patsilinakos S, Fournarakis G, Tsigas DL. Biochemical evidence of cardiac damage following transvenous implantation of a permanent antibradycardia pacemaker lead. Pacing Clin Electrophysiol 2005 28 : 1174 1181.
3. Dworschak M, Franz M, Khazen C, Czerny M, Haisjackl M, Hiesmayr M. Mechanical trauma as the major cause of troponin T release after transvenous implantation of cardioverter/defibrillators. Cardiology 2001 95 (4 212 214.
4. Bar-Or D, Winkler JV, VanBenthysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001 141 : 985 991.
5. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003 107 : 2403 2405.
6. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. Relation of Ischemia-Modified Albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 2003 92 : 322 324.
7. Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, Quiles J, et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without collaterals. Am J Cardiol 2004 93 : 88 90.
8. Sinha MK, Vazquez JM, Calvino R, Gaze DC, Collinson PO, Kaski JC. Effects of balloon occlusion during percutaneous coronary intervention on circulating ischemia modified albumin and transmyocardial lactate extraction. Heart 2000 92 : 1852 1853.
9. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, et al. Characteristics of an albumin binding test for assessment of acute coronary syndrome patients: A multicenter study. Clin Chem 2001 47 (3 464 470.
10. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, et al. Evaluation of human albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003 49 (4 581 585.
11. Sinha M, Roy D, Gaze D, Collinson P, Kaski JC. Role of "ischemia-modified albumin," a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004 21 : 29 34.
12. Peacock F, Morris LD, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006 152 : 253 262.
13. Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Kaski JCl. Effect of direct-current cardioversion on ischemia-modified albumin in patients with atrial fibrillation. Am J Cardiol 2004 93 : 366 368.
14. Roy D, Quiles J, Sinha M, Floros D, Gaze D, Collinson P, Baxter GF, et al. Effect of radiofrequency catheter ablation on the biochemical marker ischemia-modified albumin. Am J Cardiol 2004 94 : 234 236.
15. Sbarouni E, Georgiadou P, Panagiotakos D, Livanis EG, Theodorakis GN, Kremastinos DTh. Ischaemia modified albumin in radiofrequency catheter ablation. Europace 2007 9 : 127 129.
16. Van Der Zee PM, Verberne HJ, Straalen JP, Sanders GT, Van Eck-Smit BL, de Winter RJ, Fischer JC. Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem 2005 51 (9 1744 1746.
17. Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT. Ischemia-modified albumin in relation to exercise stress testing. J Am Coll Cardiol 2006 48 (12 2482 2484.
18. Kurz K, Voelker R, Zdunek D, Wergeland R, Hess G, Ivandic B, Katus H, et al. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin Res Cardiol 2006 [Epub ahead of print]
19. Beyersdorf F, Schneider M, Kreutzer J, Falk S, Zeigman M, Satter P. Studies of tissue reaction induced by transvenous pacemaker electrodes. Pacing Clin Electrophysiol 1988 11 : 1753 1759.
20. Joglar JA, Kessler DJ, Welch PJ, Keffer JH, Jessen ME, Hamdan MH, Page RL. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 1999 83 : 270 272.
21. Hurst TM, Hinrichs M, Breidenbach C, Katz N, Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999 34 : 402 408.
22. Schluter T, Baum H, Plewan A, Neumeier D. Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clin Chem 2001 47 (3 459 463.
23. Morrow DA, De Lemos JA, Sabatine MS, Antman EM. The search for a biomarker of cardiac ischemia. Clin Chem 2003 49 : 537 539.